French startup Synapse Medicine raises $8 million for medical intelligence platform that informs correct drug use - Tech.eu

#medtech #telemedicine #healthtech #startups #startuptech #ai #artificialintelligence #fundingalert #startupfunding

Synapse Medicine - Medication Intelligence , French creator of a ‘medication intelligence platform’ dedicated to correct drug use, has raised $8 million in a funding round led by by the MACSF, a French insurance provider for healthcare professionals, with the support of XAnge, BNP Paribas, BPI and Nicolas Dessaigne, co-founder of Algolia.

In a press release, the Bordeaux-based startup, co-founded by Clement Goehrs, Louis Letinier and Bruno Thiao-Layel, cited that medicines are responsible for 130,000 hospitalizations and 30,000 deaths annually in countries such as France. “That is the equivalent to the death toll and hospitalization numbers of the COVID-19 epidemic occurring every year in the country,” Synapse points out.

Applying AI to pharmacology, the team wants to ensure the safety of prescription drugs in the new age of #telemedicine by making information widely available — to healthcare institutions, professionals and the general public. The #SaaS platform is also used by #telemedicine companies, integrated into their own platforms as a turnkey prescription solution.

Read on

French startup Synapse Medicine raises $8 million for medical intelligence platform that informs correct drug use - Tech.eu

Synapse Medicine, French creator of a 'medication intelligence platform' dedicated to correct drug use, has raised $8 million in a funding round led by by the MACSF, a French insurance provider for healthcare professionals, with the support of XAnge, BNP Paribas, BPI and Nicolas Dessaigne, co-founder of Algolia.